查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1679363

北美和欧洲静脉输液帮浦市场规模、份额、趋势分析报告：按产品、适应症、最终用途、地区和细分市场预测，2025 年至 2030 年

North America And Europe Intravenous Infusion Pumps Market Size, Share & Trends Analysis Report By Product, By Disease Indication, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

市场规模和趋势

预计北美和欧洲静脉输液帮浦市场规模到 2024 年将达到 44.5 亿美元，2025 年至 2030 年的复合年增长率为 8.10%。

这种增长是由于呼吸系统疾病、中风、糖尿病、癌症和心血管疾病等慢性疾病的盛行率不断上升所致，心血管疾病是欧洲和北美的主要死亡原因。例如，根据美国卫生与公众服务部的数据，估计美国有 1.29 亿人患有至少一种主要慢性病。静脉输液帮浦在患者接受放射线治疗或化疗期间提供受管制、协调且无错误的营养物质和药物传递。使用这些泵浦可以减少管理过程中的错误。用药错误是最常见的错误类型，在治疗慢性病患者时不能掉以轻心。

我们需要更安全、更有效率、更标准化的先进输送系统。智慧型输液帮浦和下一代静脉帮浦的推出为整个帮浦市场创造了巨大的成长机会。智慧型帮浦是一种采用电脑软体系统的输液设备，旨在透过药物库来减少药物管理错误并确保安全用药。例如，2024 年 4 月，加拿大的 Mackenzie Health 成为第一个部署 BD Alaris EMR互通性的医疗系统，实现了输液帮浦和电子健康记录(EMR) 之间的双向通讯。这项进步消除了手动编程的需要，显着减少了用药错误，同时提高了工作流程效率。研究表明，输液编程所需的击键次数减少了 86%。这种智慧输液技术正在推动医院对可互通和自动输液帮浦的需求，从而推动市场成长。

先进输液帮浦技术的监管核准是静脉输液帮浦市场的关键市场驱动力，可提高医疗保健环境中的病患安全性、效率和连结性。例如，2024 年 4 月，百特国际公司 (Baxter International Inc.) 的配备 Dose IQ 安全软体的 Novum IQ 大容量输液帮浦最近获得了 FDA 510(k) 许可，从而扩展了其 Novum IQ 输液平台。此整合系统包括大容量泵和注射式帮浦，使临床医生能够在多个护理站点使用单一连接平台，提高工作流程效率并减少用药错误。随着医院越来越多地采用智慧、可互通的输液技术，对下一代输液帮浦的需求预计将大幅成长。

目录

第一章调查方法与范围

第 2 章执行摘要

3. 北美和欧洲静脉输液帮浦市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 北美和欧洲静脉输液帮浦市场分析工具
    • 产业分析—波特五力分析
    • PESTEL 分析

第四章北美和欧洲静脉输液帮浦市场-产品、估计和趋势分析

  • 北美和欧洲静脉输液帮浦市场：产品仪表板
  • 北美和欧洲静脉输液帮浦市场：产品差异分析
  • 2018-2030年北美及欧洲静脉输液帮浦市场规模、预测及趋势分析（依产品）
  • 容积式输液泵
  • 注射输液帮浦
  • 携带式输液泵
  • 患者自控镇痛输液泵
  • 植入式输液泵
  • 其他的

5. 北美和欧洲静脉输液帮浦市场（按疾病适应症、估计和趋势分析）

  • 北美和欧洲静脉输液帮浦市场：疾病指征仪表板
  • 北美及欧洲静脉输液帮浦市场：疾病适应症变异分析
  • 2018 年至 2030 年北美及欧洲静脉输液帮浦市场规模、预测及疾病适应症趋势分析
  • 化疗
  • 糖尿病
  • 胃肠病学
  • 镇痛/疼痛管理
  • 小儿科/新生儿科
  • 血液学
  • 其他的

6. 北美和欧洲静脉输液帮浦市场最终用途、预测和趋势分析

  • 北美和欧洲静脉输液帮浦市场：最终用途仪表板
  • 北美和欧洲静脉输液帮浦市场：最终用途差异分析
  • 2018-2030年北美及欧洲静脉输液帮浦市场规模、预测及趋势分析（依最终用途）
  • 医院
  • 居家医疗
  • 其他的

7. 北美和欧洲静脉输液帮浦市场-按国家、产品、疾病适应症、最终用途区域进行的估计和趋势分析

  • 北美和欧洲静脉输液帮浦市场：区域仪表板
  • 2018-2030年市场规模及预测趋势分析
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麦

第八章竞争格局

  • 主要製造商的近期趋势和影响分析
  • 公司/竞争对手分类
  • 供应商格局
    • 主要经销商和通路合作伙伴名单
    • 2024 年主要企业的市场占有率分析
    • Baxter
    • B. Braun Melsungen AG
    • Fresenius Kabi AG
    • ICU Medical, Inc.（Smiths Medical）
    • Micrel Medical Devices SA
    • Boston Scientific Corporation
    • BD
    • Terumo Corporation
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • Moog Inc.
    • IRadimed Corporation
    • CODAN Companies
    • Arcomed
Product Code: GVR-4-68040-528-7

Market Size & Trends:

The North America and Europe intravenous infusion pumps market size was valued at USD 4.45 billion in 2024 and is projected to grow at a CAGR of 8.10% from 2025 to 2030. This growth is attributed to the increase in the prevalence of chronic diseases such as respiratory diseases, stroke, diabetes, cancer, and cardiovascular diseases, wherein cardiovascular disease is the major cause of death in Europe and North America. For instance, according to the U.S. Department of Health and Human Services, an estimated 129 million people in the US have at least one major chronic disease. Intravenous infusion pumps ensure controlled, regulated, & error-free delivery of nutrients and medications while treating patients via radiation therapy or chemotherapy, as these are very complex processes and require precise dosages of medication. The use of these pumps helps in reducing errors during administration, as medication errors are the most common types of errors and cannot be taken carelessly while handling patients with chronic diseases.

There is a need for advanced delivery systems that are safer, more efficient, and standardized. The introduction of smart infusion pumps or next-generation intravenous pumps is imparting greater growth opportunities for the overall pump market. Smart pumps are infusion devices that are embedded with a computer software system aimed at decreasing drug dosing errors through the presence of drug libraries, ensuring safe medication administration. For instance, in April 2024, Mackenzie Health in Canada became the first healthcare system to implement BD Alaris EMR Interoperability, enabling two-way communication between IV infusion pumps and electronic medical records (EMRs). This advancement eliminates the need for manual programming, significantly reducing medication administration errors while improving workflow efficiency. Studies show an 86% reduction in keystrokes needed for infusion programming. Such smart infusion technologies are driving market growth by increasing hospital demand for interoperable and automated IV pumps.

Regulatory approvals of advanced infusion pump technologies are a key market driver for the intravenous infusion pump market, improving patient safety, efficiency, and connectivity in healthcare settings. For instance, in April 2024, Baxter International Inc. recently received FDA 510(k) clearance for its Novum IQ large volume infusion pump with Dose IQ Safety Software, expanding its Novum IQ Infusion Platform. This integrated system, which includes both large volume and syringe pumps, allows clinicians to use a single, connected platform across multiple care settings, enhancing workflow efficiency and reducing medication errors. As hospitals increasingly adopt smart, interoperable infusion technologies, demand for next-generation IV pumps is expected to grow significantly.

North America And Europe Intravenous Infusion Pumps Market Report Segmentation

This report forecasts revenue growth at regional & country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the North America and Europe intravenous infusion pumps market report on the basis of product, disease indication, end-use, and region:

  • Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Volumetric Infusion Pumps
  • Syringe Infusion Pumps
  • Ambulatory Infusion Pumps
  • Patient-Controlled Analgesia Infusion Pumps
  • Implantable Infusion Pumps
  • Others
  • Disease Indication Outlook (Revenue, USD Million, 2018 - 2030)
  • Chemotherapy
  • Diabetes
  • Gastroenterology
  • Analgesia/Pain Management
  • Pediatrics/Neonatology
  • Hematology
  • Others
  • End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals
  • Homecare
  • Others
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Disease Indication
    • 1.2.3. End-use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecast timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity price analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product Segment
    • 2.2.2. Disease Indication Segment
    • 2.2.3. End-use Segment
    • 2.2.4. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. North America and Europe Intravenous Infusion Pumps Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Growing prevalence of chronic diseases
      • 3.2.1.2. Technological advancements in infusion pumps
      • 3.2.1.3. Rising demand for ambulatory infusion pumps
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Lack of reimbursement
      • 3.2.2.2. Increasing product recalls
  • 3.3. North America and Europe Intravenous Infusion Pumps Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. North America and Europe Intravenous Infusion Pumps Market: Product Estimates & Trend Analysis

  • 4.1. North America and Europe Intravenous Infusion Pumps Market: Product Dashboard
  • 4.2. North America and Europe Intravenous Infusion Pumps Market: Product Movement Analysis
  • 4.3. North America and Europe Intravenous Infusion Pumps Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Volumetric Infusion Pumps
    • 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5. Syringe Infusion Pumps
    • 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.6. Ambulatory Infusion Pumps
    • 4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.7. Patient-Controlled Analgesia Infusion Pumps
    • 4.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.8. Implantable Infusion Pumps
    • 4.8.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.9. Others
    • 4.9.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. North America and Europe Intravenous Infusion Pumps Market: Disease Indication Estimates & Trend Analysis

  • 5.1. North America and Europe Intravenous Infusion Pumps Market: Disease Indication Dashboard
  • 5.2. North America and Europe Intravenous Infusion Pumps Market: Disease Indication Movement Analysis
  • 5.3. North America and Europe Intravenous Infusion Pumps Market Size & Forecasts and Trend Analysis, by Disease Indication, 2018 to 2030 (USD Million)
  • 5.4. Chemotherapy
    • 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5. Diabetes
    • 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.6. Gastroenterology
    • 5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.7. Analgesia/Pain Management
    • 5.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.8. Pediatrics/Neonatology
    • 5.8.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.9. Hematology
    • 5.9.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.10. Others
    • 5.10.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. North America and Europe Intravenous Infusion Pumps Market: End-use Estimates & Trend Analysis

  • 6.1. North America and Europe Intravenous Infusion Pumps Market: End-use Dashboard
  • 6.2. North America and Europe Intravenous Infusion Pumps Market: End-use Movement Analysis
  • 6.3. North America and Europe Intravenous Infusion Pumps Market Size & Forecasts and Trend Analysis, by End-use, 2018 to 2030 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5. Homecare
    • 6.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. North America and Europe Intravenous Infusion Pumps Market: Regional Estimates & Trend Analysis by Country, Product, Disease Indication, and End-use

  • 7.1. North America and Europe Intravenous Infusion Pumps Market: Regional Dashboard
  • 7.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
  • 7.3. North America
    • 7.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.8. Norway
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.9. Denmark
      • 7.4.9.1. Key country dynamics
      • 7.4.9.2. Regulatory framework/ reimbursement structure
      • 7.4.9.3. Competitive scenario
      • 7.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Manufacturers
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2024
    • 8.3.4. Baxter
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. End-use benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. B. Braun Melsungen AG
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. End-use benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Fresenius Kabi AG
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. End-use benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. ICU Medical, Inc. (Smiths Medical)
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. End-use benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Micrel Medical Devices SA
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. End-use benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Boston Scientific Corporation
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. End-use benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. BD
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. End-use benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Terumo Corporation
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. End-use benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. End-use benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Moog Inc.
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. End-use benchmarking
      • 8.3.13.4. Strategic initiatives
    • 8.3.14. IRadimed Corporation
      • 8.3.14.1. Company overview
      • 8.3.14.2. Financial performance
      • 8.3.14.3. End-use benchmarking
      • 8.3.14.4. Strategic initiatives
    • 8.3.15. CODAN Companies
      • 8.3.15.1. Company overview
      • 8.3.15.2. Financial performance
      • 8.3.15.3. End-use benchmarking
      • 8.3.15.4. Strategic initiatives
    • 8.3.16. Arcomed
      • 8.3.16.1. Company overview
      • 8.3.16.2. Financial performance
      • 8.3.16.3. End-use benchmarking
      • 8.3.16.4. Strategic initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. North America & Europe Intravenous Infusion Pumps Market, by Country, 2018 - 2030 (USD Million)
  • Table 4. North America & Europe Intravenous Infusion Pumps Market, by Product, 2018 - 2030 (USD Million) (Volume Unit)
  • Table 5. North America & Europe Intravenous Infusion Pumps Market, by Disease Indication, 2018 - 2030 (USD Million)
  • Table 6. North America & Europe Intravenous Infusion Pumps Market, by End Use, 2018 - 2030 (USD Million)
  • Table 7. North America Intravenous Infusion Pumps Market, by Country, 2018 - 2030 (USD Million)
  • Table 8. North America Intravenous Infusion Pumps Market, by Product, 2018 - 2030 (USD Million)
  • Table 9. North America Intravenous Infusion Pumps Market, by Disease Indication, 2018 - 2030 (USD Million)
  • Table 10. North America Intravenous Infusion Pumps Market, by End Use, 2018 - 2030 (USD Million)
  • Table 11. U.S. Intravenous Infusion Pumps Market, by Product, 2018 - 2030 (USD Million)
  • Table 12. U.S. Intravenous Infusion Pumps Market, by Disease Indication, 2018 - 2030 (USD Million)
  • Table 13. U.S. Intravenous Infusion Pumps Market, by End Use, 2018 - 2030 (USD Million)
  • Table 14. Canada Intravenous Infusion Pumps Market, by Product, 2018 - 2030 (USD Million)
  • Table 15. Canada Intravenous Infusion Pumps Market, by Disease Indication, 2018 - 2030 (USD Million)
  • Table 16. Canada Intravenous Infusion Pumps Market, by End Use, 2018 - 2030 (USD Million)
  • Table 17. Mexico Intravenous Infusion Pumps Market, by Product, 2018 - 2030 (USD Million)
  • Table 18. Mexico Intravenous Infusion Pumps Market, by Disease Indication, 2018 - 2030 (USD Million)
  • Table 19. Mexico Intravenous Infusion Pumps Market, by End Use, 2018 - 2030 (USD Million)
  • Table 20. Europe Intravenous Infusion Pumps Market, by Country, 2018 - 2030 (USD Million)
  • Table 21. Europe Intravenous Infusion Pumps Market, by Product, 2018 - 2030 (USD Million)
  • Table 22. Europe. Intravenous Infusion Pumps Market, by Disease Indication, 2018 - 2030 (USD Million)
  • Table 23. Europe Intravenous Infusion Pumps Market, by End Use, 2018 - 2030 (USD Million)
  • Table 24. Germany Intravenous Infusion Pumps Market, by Product, 2018 - 2030 (USD Million)
  • Table 25. Germany Intravenous Infusion Pumps Market, by Disease Indication, 2018 - 2030 (USD Million)
  • Table 26. Germany Intravenous Infusion Pumps Market, by End Use, 2018 - 2030 (USD Million)
  • Table 27. UK Intravenous Infusion Pumps Market, by Product, 2018 - 2030 (USD Million)
  • Table 28. UK Intravenous Infusion Pumps Market, by Disease Indication, 2018 - 2030 (USD Million)
  • Table 29. UK Intravenous Infusion Pumps Market, by End Use, 2018 - 2030 (USD Million)
  • Table 30. France Intravenous Infusion Pumps Market, by Product, 2018 - 2030 (USD Million)
  • Table 31. France Intravenous Infusion Pumps Market, by Disease Indication, 2018 - 2030 (USD Million)
  • Table 32. France Intravenous Infusion Pumps Market, by End Use, 2018 - 2030 (USD Million)
  • Table 33. Italy Intravenous Infusion Pumps Market, by Product, 2018 - 2030 (USD Million)
  • Table 34. Italy Intravenous Infusion Pumps Market, by Disease Indication, 2018 - 2030 (USD Million)
  • Table 35. Italy Intravenous Infusion Pumps Market, by End Use, 2018 - 2030 (USD Million)
  • Table 36. Spain Intravenous Infusion Pumps Market, by Product, 2018 - 2030 (USD Million)
  • Table 37. Spain Intravenous Infusion Pumps Market, by Disease Indication, 2018 - 2030 (USD Million)
  • Table 38. Spain Intravenous Infusion Pumps Market, by End Use, 2018 - 2030 (USD Million)
  • Table 39. Denmark Intravenous Infusion Pumps Market, by Product, 2018 - 2030 (USD Million)
  • Table 40. Denmark Intravenous Infusion Pumps Market, by Disease Indication, 2018 - 2030 (USD Million)
  • Table 41. Denmark Intravenous Infusion Pumps Market, by End Use, 2018 - 2030 (USD Million)
  • Table 42. Sweden Intravenous Infusion Pumps Market, by Product, 2018 - 2030 (USD Million)
  • Table 43. Sweden Intravenous Infusion Pumps Market, by Disease Indication, 2018 - 2030 (USD Million)
  • Table 44. Sweden Intravenous Infusion Pumps Market, by End Use, 2018 - 2030 (USD Million)
  • Table 45. Norway Intravenous Infusion Pumps Market, by Product, 2018 - 2030 (USD Million)
  • Table 46. Norway Intravenous Infusion Pumps Market, by Disease Indication, 2018 - 2030 (USD Million)
  • Table 47. Norway Intravenous Infusion Pumps Market, by End Use, 2018 - 2030 (USD Million)
  • Table 48. Participant's Overview
  • Table 49. Financial Performance
  • Table 50. Product Benchmarking
  • Table 51. Strategic Initiatives

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Market Formulation & Validation
  • Fig. 5 Intravenous Infusion Pumps Market, Market Segmentation
  • Fig. 6 Market Driver Analysis (Current & Future Impact)
  • Fig. 7 Market Restraint Analysis (Current & Future Impact)
  • Fig. 8 Market Opportunity Analysis (Current & Future Impact)
  • Fig. 9 Market Challenge Analysis (Current & Future Impact)
  • Fig. 10 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 11 Porter's Five Forces Analysis
  • Fig. 12 Regional Marketplace: Key Takeaways
  • Fig. 13 North America & Europe Intravenous Infusion Pumps Market, for Ultrasound, 2018 - 2030 (USD Million)
  • Fig. 14 North America & Europe Intravenous Infusion Pumps Market, for Product, 2018 - 2030 (USD Million)
  • Fig. 15 North America & Europe Intravenous Infusion Pumps Market, for Volumetric Infusion Pumps, 2018 - 2030 (USD Million)
  • Fig. 16 North America & Europe Intravenous Infusion Pumps Market, for Syringe Infusion Pumps, 2018 - 2030 (USD Million)
  • Fig. 17 North America & Europe Intravenous Infusion Pumps Market, for Ambulatory Infusion Pumps, 2018 - 2030 (USD Million) (Procedure Volume)
  • Fig. 18 North America & Europe Intravenous Infusion Pumps Market, for Patient-Controlled Analgesia Infusion Pumps, 2018 - 2030 (USD Million)
  • Fig. 19 North America & Europe Intravenous Infusion Pumps Market, for Implantable Infusion Pumps, 2018 - 2030 (USD Million)
  • Fig. 20 North America & Europe Intravenous Infusion Pumps Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 21 North America & Europe Intravenous Infusion Pumps Market, for Disease Indication, 2018 - 2030 (USD Million)
  • Fig. 22 North America & Europe Intravenous Infusion Pumps Market, for Chemotherapy, 2018 - 2030 (USD Million)
  • Fig. 23 North America & Europe Intravenous Infusion Pumps Market, for Diabetes, 2018 - 2030 (USD Million)
  • Fig. 24 North America & Europe Intravenous Infusion Pumps Market, for Gastroenterology, 2018 - 2030 (USD Million)
  • Fig. 25 North America & Europe Intravenous Infusion Pumps Market, for Analgesia/Pain Management, 2018 - 2030 (USD Million)
  • Fig. 26 North America & Europe Intravenous Infusion Pumps Market, for Pediatrics/Neonatology, 2018 - 2030 (USD Million)
  • Fig. 27 North America & Europe Intravenous Infusion Pumps Market, for Hematology, 2018 - 2030 (USD Million)
  • Fig. 28 North America & Europe Intravenous Infusion Pumps Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 29 North America & Europe Intravenous Infusion Pumps Market, for End Use, 2018 - 2030 (USD Million)
  • Fig. 30 North America & Europe Intravenous Infusion Pumps Market, for Hospitals, 2018 - 2030 (USD Million)
  • Fig. 31 North America & Europe Intravenous Infusion Pumps Market, for Homecare, 2018 - 2030 (USD Million)
  • Fig. 32 North America & Europe Intravenous Infusion Pumps Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 33 Regional Outlook, 2024 & 2030
  • Fig. 34 North America Intravenous Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. Intravenous Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 36 Canada Intravenous Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 37 Europe Intravenous Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 38 Germany Intravenous Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 39 UK Intravenous Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 40 France Intravenous Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 41 Italy Intravenous Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 42 Spain Intravenous Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 43 Denmark Intravenous Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 44 Sweden Intravenous Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 45 Norway Intravenous Infusion Pumps Market, 2018 - 2030 (USD Million)